TRANSCEND CAPITAL ADVISORS, LLC BMY Holdings History
TRANSCEND CAPITAL ADVISORS, LLC's Bristol-Myers Squibb Co Holding Summary
As of 2025-03-31, TRANSCEND CAPITAL ADVISORS, LLC held 101,072.00 shares of Bristol-Myers Squibb Co(BMY), totaling $6.16 Mil. This investment constitutes 0.44% of their stock portfolio, and TRANSCEND CAPITAL ADVISORS, LLC now holds 0% of the outstanding Bristol-Myers Squibb Co(BMY) stock.
The initial trade took place in 2019Q4. And since then TRANSCEND CAPITAL ADVISORS, LLC has made 7 purchases of BMY, at an average price of $56.35, for a total of 294,046.00 shares. In addition, there have been 14 sales at an average price of $61.15 for 192,974.00 shares. Based on historical transaction data and BMY's current price of $46.69, TRANSCEND CAPITAL ADVISORS, LLC's estimated gain on his BMY holdings is $-51,028.88, reflecting a -0.31% gain to date.
TRANSCEND CAPITAL ADVISORS, LLC BMY ($46.69) Holding Chart
TRANSCEND CAPITAL ADVISORS, LLC BMY ($46.69) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
